Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-03-28

Clinical Trial Update: Eradication of Helicobacter Pylori in the Management of Stage IE & IIE-1 Primary Low-grade B Cell Lymphoma of MALToma [NA]

View source ↗

Summary

A completed clinical trial evaluated whether eradicating Helicobacter pylori can aid treatment of early-stage primary MALT lymphoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: National Health Research Institutes, Taiwan | Conditions: MALT Lymphoma | NA | Status: COMPLETED